Relieves coughs and upper respiratory symptoms associated with allergy or the common cold. ANDA 200386, held by Cosette Pharmaceuticals. Codeine Phosphate; Promethazine Hydrochloride.
As of Nov 21, 2026, ANDA 200386 (Promethazine Hydrochloride and Codeine Phosphate), held by Cosette Pharmaceuticals, was first approved by FDA on Jun 29, 2012, with 8 approved supplements and 0 published complete response letters.
Promethazine HCl and Codeine Phosphate Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. Important Limitations of Use Not indicated for pediatric patients under 18 years of age. Contraindicated in pediatric patients under 12 years of age. Contraindicated in pediatric patients 12 to 18 years of age after tonsillectomy or adenoidectomy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride and Codeine Phosphate10MG/5ML;6.25MG/5ML · syrup;oral | Codeine Phosphate; Promethazine Hydrochloride | Rx |
| Dec 29, 2025 | Supplement 19Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 16Labeling · Standard review | Approved | None posted |
| Dec 5, 2023 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jun 28, 2018 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jun 26, 2018 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 29, 2017 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jan 13, 2017 | Supplement 3Labeling · Standard review | Approved | None posted |
| May 10, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 29, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters